
Welcome to the refreshed format of The Longevity Letter.
My goal for 2026 is simple: High signal, low noise. You are busy, and the longevity space is getting louder, not clearer. I’ve redesigned this newsletter to be your weekly "Insider’s Rounds"—a briefing on what matters, what works, and what I’m personally testing.
We are moving from general advice to specific, actionable intelligence.
The TL;DR if you only have 30 seconds:
👻 The Deep Dive: Why I’m treating the Shingles vaccine as an anti-aging drug (and the concept of the "Viral Ghost").
💊 The Protocol: My personal battle with post-COVID immunosenescence, and why Low Dose Naltrexone (LDN) was a game-changer for me.
📉 The Chart: The "Shingrix Gap"—how one vaccine bought patients 17% more dementia-free time.
⚡ Quick Hits: NVIDIA’s robot labs, Stanford’s sleep predictions, and the T-cell breakthrough.
Let's get into it.
🩸 The Deep Dive: The "Ghost War" in Your Blood
If you think of the Shingles vaccine simply as "rash prevention," you are missing the bigger picture. Yes, it prevents a painful outbreak in anyone with a history of Chickenpox (I’ve had Shingles twice—I know the misery).
But new data from USC (published this week, Jan 20) suggests the Shingrix vaccine might be one of the most powerful anti-aging interventions we have.
